SWTX
SpringWorks Therapeutics
SWTX
SWTX
Delisted
SWTX was delisted on the 30th of June, 2025.
147 hedge funds and large institutions have $1.58B invested in SpringWorks Therapeutics in 2023 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 54 increasing their positions, 48 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
13% less capital invested
Capital invested by funds: $1.82B → $1.58B (-$242M)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
43% less call options, than puts
Call options by funds: $256K | Put options by funds: $453K
Holders
147
Holding in Top 10
4
Calls
$256K
Puts
$453K
Top Buyers
| 1 | +$14.7M | |
| 2 | +$4.97M | |
| 3 | +$4.33M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
+$4.12M |
| 5 |
BlackRock
New York
|
+$3.85M |
Top Sellers
| 1 | -$25.1M | |
| 2 | -$13.5M | |
| 3 | -$7.28M | |
| 4 |
Goldman Sachs
New York
|
-$7.26M |
| 5 |
O
OrbiMed
New York
|
-$4.86M |